Dynamic data-driven meta-analysis for prioritisation of host genes implicated in COVID-19.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 12 2020
Historique:
received: 24 09 2020
accepted: 02 12 2020
entrez: 19 12 2020
pubmed: 20 12 2020
medline: 5 1 2021
Statut: epublish

Résumé

The increasing body of literature describing the role of host factors in COVID-19 pathogenesis demonstrates the need to combine diverse, multi-omic data to evaluate and substantiate the most robust evidence and inform development of therapies. Here we present a dynamic ranking of host genes implicated in human betacoronavirus infection (SARS-CoV-2, SARS-CoV, MERS-CoV, seasonal coronaviruses). We conducted an extensive systematic review of experiments identifying potential host factors. Gene lists from diverse sources were integrated using Meta-Analysis by Information Content (MAIC). This previously described algorithm uses data-driven gene list weightings to produce a comprehensive ranked list of implicated host genes. From 32 datasets, the top ranked gene was PPIA, encoding cyclophilin A, a druggable target using cyclosporine. Other highly-ranked genes included proposed prognostic factors (CXCL10, CD4, CD3E) and investigational therapeutic targets (IL1A) for COVID-19. Gene rankings also inform the interpretation of COVID-19 GWAS results, implicating FYCO1 over other nearby genes in a disease-associated locus on chromosome 3. Researchers can search and review the gene rankings and the contribution of different experimental methods to gene rank at https://baillielab.net/maic/covid19 . As new data are published we will regularly update the list of genes as a resource to inform and prioritise future studies.

Identifiants

pubmed: 33339864
doi: 10.1038/s41598-020-79033-3
pii: 10.1038/s41598-020-79033-3
pmc: PMC7749145
doi:

Substances chimiques

CD3 Complex 0
CD3E protein, human 0
CD4 Antigens 0
CXCL10 protein, human 0
Chemokine CXCL10 0
FYCO1 protein, human 0
IL1A protein, human 0
Interleukin-1alpha 0
Microtubule-Associated Proteins 0
Cyclosporine 83HN0GTJ6D
Cyclophilin A EC 5.2.1.-

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

22303

Subventions

Organisme : Medical Research Council
ID : MC_PC_19025
Pays : United Kingdom

Références

Clin Microbiol Rev. 2008 Jan;21(1):13-25
pubmed: 18202435
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Viruses. 2021 Apr 09;13(4):
pubmed: 33918958
Nat Commun. 2018 Sep 6;9(1):3603
pubmed: 30190477
J Virol. 2021 Jan 13;95(3):
pubmed: 33177207
Pharmacol Ther. 2020 Sep;213:107587
pubmed: 32470470
PLoS Pathog. 2009 Aug;5(8):e1000546
pubmed: 19680534
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Cell Death Dis. 2013 Oct 31;4:e888
pubmed: 24176846
Gastroenterology. 2005 Sep;129(3):1031-41
pubmed: 16143140
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Nat Microbiol. 2020 Nov;5(11):1330-1339
pubmed: 32704094
N Engl J Med. 2020 Oct 15;383(16):1522-1534
pubmed: 32558485
PLoS One. 2015 Aug 11;10(8):e0134707
pubmed: 26263487
Hum Genomics. 2020 Sep 11;14(1):30
pubmed: 32917282
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Immunol Res. 2020 Jun;68(3):161-168
pubmed: 32524333
Am J Respir Crit Care Med. 2021 Jan 15;203(2):192-201
pubmed: 33217246
Inflamm Res. 2008 Nov;57(11):519-23
pubmed: 19109744
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Hepatology. 2003 Nov;38(5):1282-8
pubmed: 14578868
Nucleic Acids Res. 2016 Jan 4;44(D1):D7-19
pubmed: 26615191
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
Cytokine Growth Factor Rev. 2011 Jun;22(3):121-30
pubmed: 21802343
PLoS Biol. 2008 Sep 16;6(9):e226
pubmed: 18798692
Bioinformatics. 2012 Feb 15;28(4):573-80
pubmed: 22247279
PLoS One. 2012;7(2):e31063
pubmed: 22347431
Cytokine. 2021 Jan;137:155302
pubmed: 33002740
J Virol. 2015 Apr;89(8):4434-48
pubmed: 25653449
Lancet Rheumatol. 2020 Aug;2(8):e474-e484
pubmed: 32835257
Science. 2014 May 23;344(6186):807-8
pubmed: 24855243
Hepatology. 2009 May;49(5):1460-8
pubmed: 19353740
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
J Gastroenterol. 2003;38(6):567-72
pubmed: 12825133
Nat Commun. 2020 Jan 9;11(1):164
pubmed: 31919360
Sci Rep. 2017 Mar 28;7(1):483
pubmed: 28352119
Sci Rep. 2015 Nov 03;5:16119
pubmed: 26524966
Cytokine Growth Factor Rev. 2020 Jun;53:25-32
pubmed: 32446778
Viruses. 2011 Sep;3(9):1610-23
pubmed: 21994798
PLoS Pathog. 2011 Oct;7(10):e1002331
pubmed: 22046132
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nat Immunol. 2018 Jun;19(6):625-635
pubmed: 29777224
J Intensive Care. 2020 May 24;8:36
pubmed: 32483488
Lancet Rheumatol. 2020 Aug;2(8):e465-e473
pubmed: 32835256
medRxiv. 2020 May 06;:
pubmed: 32511488
Cell Host Microbe. 2020 Jun 10;27(6):879-882.e2
pubmed: 32359396
J Infect. 2013 Jul;67(1):84-5
pubmed: 23396219
J Virol. 2008 Sep;82(17):8887-90
pubmed: 18562523
Ann Rheum Dis. 2018 Jun;77(6):840-847
pubmed: 29472362
Front Microbiol. 2020 Nov 25;11:593857
pubmed: 33324374
Antimicrob Agents Chemother. 2008 Apr;52(4):1302-17
pubmed: 18212100
Lancet Rheumatol. 2020 Jun;2(6):e325-e331
pubmed: 32501454
PLoS One. 2012;7(5):e37277
pubmed: 22615963

Auteurs

Nicholas Parkinson (N)

Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, EH25 9RG, UK.

Natasha Rodgers (N)

Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, EH25 9RG, UK.

Max Head Fourman (M)

Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, EH25 9RG, UK.

Bo Wang (B)

Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, EH25 9RG, UK.

Marie Zechner (M)

Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, EH25 9RG, UK.

Maaike C Swets (MC)

Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, EH25 9RG, UK.
Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.

Jonathan E Millar (JE)

Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, EH25 9RG, UK.

Andy Law (A)

Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, EH25 9RG, UK.

Clark D Russell (CD)

Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, EH25 9RG, UK.
University of Edinburgh Centre for Inflammation Research, The Queen's Medical Research Institute, Edinburgh, UK.

J Kenneth Baillie (JK)

Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, EH25 9RG, UK. j.k.baillie@ed.ac.uk.

Sara Clohisey (S)

Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, EH25 9RG, UK. sara.clohisey@roslin.ed.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH